Kathmere Capital Management, LLC Amgen Inc Transaction History

Kathmere Capital Management, LLC

$1.02 Billion
Q3 2024

A detailed history of Kathmere Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 3,111 shares of AMGN stock, worth $916,282. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,111

Previous 2,895 7.46%

Holding current value

$916,282

Previous $904,000 10.84%

% of portfolio

0.1%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $66,826 - $72,874	216 Added 7.46%	3,111 $1 Million
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $4,466 - $5,428	-17 Reduced 0.58%	2,895 $904,000
Q2 2024 Jul 01, 2024	BUY	$262.75 - $319.31 $78,036 - $94,835	297 Added 11.36%	2,912 $909,000
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $79,854 - $96,394	-297 Reduced 10.2%	2,615 $743,000
Q4 2023 Apr 16, 2024	SELL	$255.7 - $288.46 $121,713 - $137,306	-476 Reduced 14.05%	2,912 $838,000
Q3 2023 Oct 11, 2023	BUY	$218.65 - $271.46 $299,550 - $371,900	1,370 Added 67.89%	3,388 $910,000
Q2 2023 Jul 11, 2023	SELL	$214.27 - $253.37 $677,950 - $801,662	-3,164 Reduced 61.06%	2,018 $448,000
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $203,888 - $248,505	903 Added 21.1%	5,182 $1.25 Million
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $364,844 - $463,578	1,593 Added 48.32%	4,890 $0
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $139,937 - $177,807	-611 Reduced 12.49%	4,279 $0
Q3 2022 Oct 11, 2022	SELL	$224.46 - $253.15 $94,497 - $106,576	-421 Reduced 11.32%	3,297 $743,000
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $140,733 - $156,611	610 Added 19.63%	3,718 $905,000
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $404,991 - $448,026	1,847 Added 146.47%	3,108 $752,000
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $113,759 - $130,187	-572 Reduced 31.21%	1,261 $284,000
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $13,373 - $15,668	-63 Reduced 3.32%	1,833 $390,000
Q3 2020 Nov 20, 2020	SELL	$234.65 - $260.95 $178,099 - $198,061	-759 Reduced 28.59%	1,896 $482,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $622,995 - $692,822	2,655 New	2,655 $653,000
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $220,692 - $292,698	-1,211 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $229,133 - $294,515	1,211 New	1,211 $292,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.

Account

Kathmere Capital Management, LLC Amgen Inc Transaction History